The antiviral baloxavir significantly reduced household transmission of influenza compared with placebo. The drug showed consistent effects across age groups, virus types, and countries, with no new ...

Expert Rev Pharmacoeconomics Outcomes Res. 2008;8(6):563-573. Influenza is responsible for a great number of cases each year and, consequently, high healthcare costs. Influenza vaccination is the ...

Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral ...

Antiviral drugs commonly used to treat non-severe influenza appeared to have little or no effect on key clinical outcomes, except for baloxavir (Xofluza), according to a systematic review and ...

Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a recent study reports an underuse of the treatment. Despite national ...

Infectious diseases are becoming more frequent, more severe, and harder to control in our closely connected world. Viruses spread rapidly because of changing climates, crowded cities, and increased ...

The flu can also cause a general feeling of fatigue or malaise, Ray says, as well as gastrointestinal issues like diarrhea ...

DNA scaffolds that mirror influenza virus protein geometry boost antiviral binding and reduce infection more effectively than free molecules, enabling a modular antiviral design strategy.

The most effective defense against an influenza pandemic would be a directed vaccine to elicit a specific immune response toward the strain or strains of influenza virus. However, until there is an ...